The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 27, Pages 3556-3567
Publisher
Springer Nature
Online
2014-09-08
DOI
10.1038/onc.2014.284
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune Response
- (2012) E. A. Mittendorf et al. CANCER RESEARCH
- Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
- (2012) James S. Duncan et al. CELL
- Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion
- (2012) Huan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Food-Grade Bacteria Expressing Elafin Protect Against Inflammation and Restore Colon Homeostasis
- (2012) J.-P. Motta et al. Science Translational Medicine
- Proteolytic cleavage of elafin by 20S proteasome may contribute to inflammation in acute lung injury
- (2012) Aoife Kerrin et al. THORAX
- Epigenetic regulation of the transcription factor Foxa2 directs differential elafin expression in melanocytes and melanoma cells
- (2011) Kyung Sook Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cdk2 is Required for Breast Cancer Mediated by the Low-Molecular-Weight Isoform of Cyclin E
- (2011) S. Akli et al. CANCER RESEARCH
- Neutrophil Elastase Acts as a Biased Agonist for Proteinase-activated Receptor-2 (PAR2)
- (2011) Rithwik Ramachandran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two Phases of Mitogenic Signaling Unveil Roles for p53 and EGR1 in Elimination of Inconsistent Growth Signals
- (2011) Yaara Zwang et al. MOLECULAR CELL
- The Neutrophil Elastase Inhibitor Elafin Triggers Rb-Mediated Growth Arrest and Caspase-Dependent Apoptosis in Breast Cancer
- (2010) J. A. Caruso et al. CANCER RESEARCH
- Pharmacology and therapeutics: Neutrophil elastase promotes proliferation of HaCaT cell line and transwell psoriasis organ culture model
- (2010) Xichuan Yang et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth
- (2010) A McGarry Houghton et al. NATURE MEDICINE
- Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
- (2010) B. Korkmaz et al. PHARMACOLOGICAL REVIEWS
- Plasma Neutrophil Elastase and Elafin Imbalance Is Associated with Acute Respiratory Distress Syndrome (ARDS) Development
- (2009) Zhaoxi Wang et al. PLoS One
- Neutrophil elastase, proteinase 3 and cathepsin G: Physicochemical properties, activity and physiopathological functions
- (2007) Brice Korkmaz et al. BIOCHIMIE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started